{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T21:53:32Z","timestamp":1772229212976,"version":"3.50.1"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Antibodies against voltage-gated potassium channel (VGKC) complexes include anti-LGI1 and anti-CASPR2. Anti-ADAM23 antibodies have not been previously reported in autoimmune encephalitis (AE).<\/jats:p><\/jats:sec><jats:sec><jats:title>Case report<\/jats:title><jats:p>We report a 71-year-old female patient who presented with rapidly progressive short-term memory loss, psychobehavioural abnormalities, and impaired consciousness. Six months earlier, she had recovered from herpes simplex encephalitis (HSE). Cerebrospinal fluid (CSF) analysis suggested lymphocytic inflammation. AE was considered after the exclusion of HSV reactivation and other infectious etiologies. A comprehensive screening for commercially available autoimmune and paraneoplastic antibodies yielded negative results. A tissue-based assay (TBA) of CSF revealed a pattern of neuropil reactivity (neuropil pattern, suggesting the presence of neuronal surface antibodies (NS-Ab). A laboratory-developed antibody panel screening using a cell-based assay (CBA) identified an anti-ADAM23 antibody. Immunofluorescence staining showed that ADAM23 colocalized with Tuj1, which is expressed on the surface of neurons. Subclass analysis revealed that the anti-ADAM23 antibody predominantly belonged to the IgG4 subclass. Finally, the patient was diagnosed with an anti-ADAM23 antibody-associated AE. During the early stages of the disease, the patient underwent several courses of intravenous immunoglobulin (IVIg) with limited efficacy. Following the addition of high-dose methylprednisolone pulse therapy, the patient's consciousness improved from coma to stupor and the seizures were relieved.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We propose that anti-ADAM23 antibody, a previously overlooked autoantibody targeting the VGKC complex, may have diagnostic significance for autoimmune encephalitis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1589360","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T05:42:55Z","timestamp":1748583775000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case Report: Anti-ADAM23 antibody: an overlooked autoantibody against VGKC-complex in autoimmune encephalitis"],"prefix":"10.3389","volume":"16","author":[{"given":"Pinfei","family":"Ni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyuan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongzhi","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"B2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrneurol.2017.43","article-title":"The value of lgi1, caspr2 and voltage-gated potassium channel antibodies in encephalitis","volume":"13","author":"van Sonderen","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2016-314758","article-title":"Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies","volume":"88","author":"Lang","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.592","article-title":"Insights from lgi1 and caspr2 potassium channel complex autoantibody subtyping","volume":"70","author":"Klein","year":"2013","journal-title":"JAMA Neurol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad238","article-title":"Neurologic complications in herpes simplex encephalitis: clinical, immunological and genetic studies","volume":"146","author":"Armangue","year":"2023","journal-title":"Brain"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30244-8","article-title":"Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: A prospective observational study and retrospective analysis","volume":"17","author":"Armangue","year":"2018","journal-title":"Lancet Neurol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad419","article-title":"The immunobiology of herpes simplex virus encephalitis and post-viral autoimmunity","volume":"147","author":"Cleaver","year":"2024","journal-title":"Brain"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-022-10973-8","article-title":"The importance of tissue-based assay in the diagnosis of autoimmune encephalitis","volume":"269","author":"Gadoth","year":"2022","journal-title":"J Neurol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1066830","article-title":"Neuronal surface antigen-specific immunostaining pattern on a rat brain immunohistochemistry in autoimmune encephalitis","volume":"13","author":"Nagata","year":"2022","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.20320","article-title":"Adam23 is a cell-surface glycoprotein expressed by central nervous system neurons","volume":"78","author":"Goldsmith","year":"2004","journal-title":"J Neurosci Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.04.012","article-title":"Adam23 is a negative regulator of K(V)1.1\/K(V)1.4 potassium currents","volume":"704","author":"Lancaster","year":"2019","journal-title":"Neurosci Lett"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1038\/s41467-018-03947-w","article-title":"Structural basis of epilepsy-related ligand-receptor complex lgi1-Adam22","volume":"9","author":"Yamagata","year":"2018","journal-title":"Nat Commun"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1186\/s12863-017-0478-6","article-title":"Adam23 is a common risk gene for canine idiopathic epilepsy","volume":"18","author":"Koskinen","year":"2017","journal-title":"BMC Genet"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2009.09.008","article-title":"Lgi1-associated epilepsy through altered Adam23-dependent neuronal morphology","volume":"42","author":"Owuor","year":"2009","journal-title":"Mol Cell Neurosci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-017-0045-1","article-title":"Adam23 promotes neuronal differentiation of human neural progenitor cells","volume":"22","author":"Markus-Koch","year":"2017","journal-title":"Cell Mol Biol Lett"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1069368","article-title":"The diagnosis of anti-lgi1 encephalitis varies with the type of immunodetection assay and sample examined","volume":"13","author":"Munoz-Sanchez","year":"2022","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1346671","article-title":"Exploring the depths of igg4: insights into autoimmunity and novel treatments","volume":"15","author":"Unlu","year":"2024","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2021-327302","article-title":"Lgi1 antibody encephalitis: acute treatment comparisons and outcome","volume":"93","author":"Rodriguez","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1589360\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T05:42:56Z","timestamp":1748583776000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1589360\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":18,"alternative-id":["10.3389\/fimmu.2025.1589360"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1589360","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"article-number":"1589360"}}